stars 1 stars 2 stars 3

Cellex Cell Professionals is a full-service CDMO for cell therapy Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide. Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release. In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers' needs, based on profound experience with EU and FDA regulations. Cellex also stands for a successful tech transfer of processes from US to Europe. Our apheresis centers have all techniques for collection of different starting materials from healthy donors. Cellex runs its own highly diverse donor pool and offers leukopak, bone marrow or whole blood products customized for R&D, clinical or commercial purposes. IT and transport solutions complete the Cellex portfolio.

Cellex Cell Professionals Questions

The Cellex Cell Professionals annual revenue was $27.5 million in 2026.

Anja Böhme is the CFO of Cellex Cell Professionals.

160 people are employed at Cellex Cell Professionals.

Top Cellex Cell Professionals Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users